TSI Group’s Hobamine could reduce oxidative stress and support healthy immune function, shows study

04 Apr 2023 — Supplementation with 2-hydroxybenzylamine (2-HOBA) could reduce inflammation in both younger and older adults according to the National Institutes of Health (NIH). Using TSI Group’s 2-HOBA acetate offering, Hobamine, the study reports significant increase in i biomarkers related to immunity and inflammation.